Rapid Micro Biosystems revenue was $26.17M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $7.6M, up 14.9% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, RPID annual revenue was $22.5M, with 31.4% growth year-over-year.
RPID past revenue growth
How has RPID's revenue growth performed historically?
Rapid Micro Biosystems (NASDAQ: RPID) reported Q3 2024 revenue of $7.60 million up 23.74% year over year. In the same quarter last year, Rapid Micro Biosystems's revenue was $6.15 million.
What was Rapid Micro Biosystems's revenue in 2023?
Rapid Micro Biosystems's annual revenue for the twelve months ending Dec 31, 2023 was $22.52 million, a 31.44% increase year over year.
How much does Rapid Micro Biosystems make in a day?
Based on Rapid Micro Biosystems annual revenue for the past four years, RPID makes an average of $54,082.88 per day.
What was Rapid Micro Biosystems's annual revenue growth in the past year?
As of Q1 2025, Rapid Micro Biosystems's revenue has grown 27.31% year over year. This is 16.01 percentage points higher than the US Medical Devices industry revenue growth rate of 11.3%. Rapid Micro Biosystems's revenue in the past year totaled $26.17 million.
How much does Rapid Micro Biosystems make in a year?
Rapid Micro Biosystems's revenue by year for the past four years is:
Rapid Micro Biosystems's revenue for the twelve months ending Dec 31, 2023 was $22.52 million, a 31.44% increase year over year.
Rapid Micro Biosystems's annual revenue for Dec 31, 2022 was $17.13 million, a 26.25% decrease from 2021.
Rapid Micro Biosystems's annual revenue for 2021 was $23.23 million, a 44.5% increase from 2020.
Rapid Micro Biosystems's annual revenue for 2020 was $16.08 million, a 2.63% decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.